WPG Advisers’s CONMED CNMD Stock Holding History

WPG Advisers’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-26	Closed	-$1.35K	–	1457
2025 Q2	$1.35K	Buy	26 +11	+73%	+$604	﹤0.01%	1206
2025 Q1	$906	Sell	15 -8	-35%	-$516	﹤0.01%	1272
2024 Q4	$1.57K	Buy	+23	New	+$1.6K	﹤0.01%	1128

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WPG Advisers's CNMD Position: Q3 2025 in Review

WPG Advisers sold out of CONMED (CNMD) in Q3 2025, closing a stake of 26 shares — an estimated $1.35K sold.

WPG Advisers first reported a position in CNMD in Q4 2024 and held it in 3 quarters. The position peaked at $1.57K in Q4 2024. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

WPG Advisers reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
WPG Advisers sold 26 CONMED shares in Q3 2025, an estimated $1.35K.
WPG Advisers first reported a position in CONMED in Q4 2024 and held it in 3 quarters.
WPG Advisers's CONMED position peaked at $1.57K in Q4 2024.
273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on WPG Advisers's 13F filing for Q3 2025, filed 29 Oct 2025.